Financials data is unavailable for this security.
View more
Year on year Traws Pharma Inc had revenues remain flat at 226.00k, though the company grew net income from a loss of 18.96m to a smaller loss of 18.95m.
Gross margin | -- |
---|---|
Net profit margin | -60,641.15% |
Operating margin | -61,111.06% |
Return on assets | -557.63% |
---|---|
Return on equity | -- |
Return on investment | -896.39% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Traws Pharma Inc fell by 17.94m. Cash Flow from Investing was negative at 14.00k, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 17.93m for operations while cash used for financing totalled .
Cash flow per share | -6.20 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.241 |
---|---|
Tangible book value per share | 0.241 |
More ▼
Balance sheet in USDView more
Current ratio | 1.88 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼